Heres what you need to know: Target Tissue: Works specifically on adipose tissue without systemic growth hormone effects or muscle tissue impact Mechanism: Activates beta-3 adrenergic receptors on fat cell membranes, triggering intracellular fat-burning cascades Primary Action: Stimulates hormone-sensitive lipase to break down stored triglycerides into free fatty acids for energy utilization Secondary Action: Inhibits lipogenic enzymes that convert excess calories into stored fat Regional Selectivity: Particularly effective on visceral (deep abdominal) and subcutaneous fat deposits with high beta-3 receptor concentration Preservation Effect: Targets fat tissue selectively without promoting muscle protein breakdown or affecting lean tissue Unique Advantage: Does not bind to growth hormone receptors, avoiding effects on IGF-1, glucose metabolism, or insulin sensitivity Research Validation: Clinical trials with 900+ participants confirmed selective fat metabolism effects with excellent safety profile The following guide provides detailed analysis of how AOD-9604 targets fat cells, from receptor binding to metabolic outcomes
Non-Stimulant Metabolic Support 5-Amino-1MQ does not rely on stimulants or appetite suppressants, making it a targeted metabolic-support option
An orally available NNMT inhibitor if the animal bioavailability data translates to humans would have significant practical advantages
subscribe to newsletter Be the first to know about new products & special offers from Pure Health Peptides!
Quality Comparison 5-Amino-1MQ Research Overview 5-Amino-1MQ is a research compound commonly studied in relation to NNMT inhibition , metabolic signaling, cellular energy regulation, and adipocyte-related research models
